Uncategorized files

Showing below up to 50 results in range #5,351 to #5,400.

• 
  Angiomyolipoma gross.JPG 1,024 × 822; 81 KB
  
• 
  AngiosarcomaGross.JPG 800 × 638; 110 KB
  
• 
  Angiosarcoma (5617087462) (1).jpg 1,976 × 1,415; 945 KB
  
• 
  Angiosarcoma gross pathology.jpg 1,600 × 1,146; 401 KB
  
• 
  Angiostrong LifeCycle.gif 435 × 483; 56 KB
  
• 
  Angiostrongylus cantonensis.png 287 × 429; 41 KB
  
• 
  Angiotensen ll (Giapreza) Clinical Studies Figure.png 1,312 × 1,202; 1.47 MB
  
• 
  Angiotensen ll (Giapreza) Dosage Table.png 1,034 × 460; 71 KB
  
• 
  AngiotensinCE-1O8A.png 424 × 358; 89 KB
  
• 
  Angiotensin II (Giapreza) Molecular Structure.png 1,338 × 556; 258 KB
  
• 
  Angiotensin II (Giapreza) Package Label 1.jpeg 725 × 240; 39 KB
  
• 
  Angiotensin II (Giapreza) Package Label 2.jpeg 1,372 × 1,151; 143 KB
  
• 
  Angiotensin II (Giapreza) Pharmocology Box Image.png 2,598 × 1,390; 551 KB
  
• 
  Angiotensinamide svg.png 592 × 599; 21 KB
  
• 
  Angiotensins I and II comparison.png 800 × 527; 172 KB
  
• 
  Angkordemon.jpg 240 × 165; 12 KB
  
• 
  Angle louis1.jpg 640 × 480; 54 KB
  
• 
  Angle louis2.jpg 920 × 960; 140 KB
  
• 
  Angry plt.ppt ; 110 KB
  
• 
  Angular chelitis.jpg 768 × 512; 257 KB
  
• 
  Anhedonia.png 1,122 × 616; 17 KB
  
• 
  Anhidrotic ectodermal dysplasia.jpg 768 × 512; 215 KB
  
• 
  Anhidrotic ectodermal dysplasia 001.jpg 768 × 512; 236 KB
  
• 
  Anidulafungin.JPG 752 × 631; 80 KB
  
• 
  Anidulafungin 100 mg.png 630 × 371; 207 KB
  
• 
  Anidulafungin 100 mg FDA package label.png 620 × 1,333; 118 KB
  
• 
  Anidulafungin 50 mg.png 638 × 284; 186 KB
  
• 
  Anidulafungin 50 mg FDA package label.png 620 × 941; 88 KB
  
• 
  Anidulafungin Adverse reactions Candidemia and other Candida Infections.png 630 × 2,067; 220 KB
  
• 
  Anidulafungin Adverse reactions Esophageal Candidiasis.png 628 × 858; 99 KB
  
• 
  Anidulafungin Endoscopy Results in Patients with Esophageal Candidiasis.png 623 × 462; 54 KB
  
• 
  Anidulafungin Global Response and Mortality in Candidemia and other Candida Infections.png 625 × 881; 89 KB
  
• 
  Anidulafungin Global Success in patients with Candidemia and other Candida Infections.png 625 × 462; 60 KB
  
• 
  Anidulafungin Patient Disposition and Reasons for Discontinuation in Candidemia and other Candida Infections Study.png 623 × 331; 38 KB
  
• 
  Anidulafungin Pharmacokinetic.png 637 × 528; 68 KB
  
• 
  Anidulafungin Structure.png 457 × 248; 21 KB
  
• 
  Anidulafungin Structure (2).png 266 × 455; 22 KB
  
• 
  Anifrolumab-fnia Drug Label.png 1,312 × 788; 1,003 KB
  
• 
  Anifrolumab-fnia Drug Packaging.png 658 × 1,158; 171 KB
  
• 
  Anifrolumab-fnia Figure 1 Trial 3 Data.png 670 × 438; 87 KB
  
• 
  Anifrolumab-fnia Package Insert 1 .png 672 × 1,464; 323 KB
  
• 
  Anifrolumab-fnia Package Insert 2.png 638 × 928; 182 KB
  
• 
  Anifrolumab-fnia Table 1 Adverse Reactions.png 1,312 × 1,370; 197 KB
  
• 
  Anifrolumab-fnia Table 2 Baseline.png 664 × 1,220; 149 KB
  
• 
  Anifrolumab-fnia Table 3 BICLA.png 672 × 944; 159 KB
  
• 
  Anifrolumab-fnia Table 4 SRI.png 670 × 936; 159 KB
  
• 
  Aniger pda.jpg 320 × 240; 31 KB
  
• 
  Anileridine.png 265 × 479; 10 KB
  
• 
  Aniline-2D-skeletal.png 378 × 599; 10 KB
  
• 
  Aniline-3D-vdW.png 869 × 1,100; 132 KB